Literature DB >> 11508997

Stimulation by thimerosal of histamine-induced Ca(2+) release in intact HeLa cells seen with aequorin targeted to the endoplasmic reticulum.

M Montero1, M J Barrero, F Torrecilla, C D Lobatón, A Moreno, J Alvarez.   

Abstract

The oxidizing thiol reagent, thimerosal, has been shown to activate reversibly the inositol 1,4,5-trisphosphate (InsP(3)) receptor in several cell types. We have studied here the effects of thimerosal by monitoring the [Ca(2+)] inside the endoplasmic reticulum (ER) of intact HeLa cells with targeted aequorin. We show that thimerosal produced little effects on the ER-Ca(2+)-pump and only slightly increased the ER-Ca(2+)-leak in intact cells. Instead, thimerosal increased the sensitivity to histamine of ER-Ca(2+)-release by about two orders of magnitude, made the response much more prolonged at saturating histamine concentrations and enhanced both cytosolic and mitochondrial [Ca(2+)] responses to histamine. Moreover, inhibition of ER-Ca(2+)release by cytosolic [Ca(2+)] microdomains was fully preserved and sensitive to BAPTA-loading, and histamine-induced Ca(2+) release remained quantal in the presence of both thimerosal and intracellular BAPTA. The effects of thimerosal were reversible in the presence of dithiotreitol, suggesting the possible presence of a physiological redox regulatory mechanism. However, in permeabilized cells thimerosal potentiated InsP(3)-induced Ca(2+) release but oxidized glutathione had no effect. In addition, thimerosal increased the [Ca(2+)](ER) steady-state level in permeabilized cells. Thimerosal partially inhibited also plasma membrane Ca(2+)extrusion and increased Ca(2+)(Mn(2+)) entry through the plasma membrane, both phenomena contributing to increase the steady-state cytosolic [Ca(2+)]. Thimerosal-induced Ca(2+) entry was additive to that induced by emptying of the ER, suggesting that store-operated Ca(2+) channels may not be involved. These results provide new insights on the mechanisms of activation and inactivation of InsP(3) receptors. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11508997     DOI: 10.1054/ceca.2001.0224

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  6 in total

1.  Redox-regulated heterogeneous thresholds for ligand recruitment among InsP3R Ca2+-release channels.

Authors:  Horia Vais; Adam P Siebert; Zhongming Ma; Marisabel Fernández-Mongil; J Kevin Foskett; Don-On Daniel Mak
Journal:  Biophys J       Date:  2010-07-21       Impact factor: 4.033

2.  STIM2 is a feedback regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+ levels.

Authors:  Onn Brandman; Jen Liou; Wei Sun Park; Tobias Meyer
Journal:  Cell       Date:  2007-12-28       Impact factor: 41.582

3.  STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx.

Authors:  Jen Liou; Man Lyang Kim; Won Do Heo; Joshua T Jones; Jason W Myers; James E Ferrell; Tobias Meyer
Journal:  Curr Biol       Date:  2005-07-12       Impact factor: 10.834

4.  Co-incident signalling between mu-opioid and M3 muscarinic receptors at the level of Ca2+ release from intracellular stores: lack of evidence for Ins(1,4,5)P3 receptor sensitization.

Authors:  Damien S K Samways; Wen-hong Li; Stuart J Conway; Andrew B Holmes; Martin D Bootman; Graeme Henderson
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 5.  Structural Mechanisms of Store-Operated and Mitochondrial Calcium Regulation: Initiation Points for Drug Discovery.

Authors:  Megan Noble; Qi-Tong Lin; Christian Sirko; Jacob A Houpt; Matthew J Novello; Peter B Stathopulos
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

Review 6.  Thimerosal exposure and the role of sulfation chemistry and thiol availability in autism.

Authors:  Janet K Kern; Boyd E Haley; David A Geier; Lisa K Sykes; Paul G King; Mark R Geier
Journal:  Int J Environ Res Public Health       Date:  2013-08-20       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.